Home
Karuna Health, Inc.

Karuna Health, Inc. Market Share Analysis for March 2026

Products Archive - Karuna Health

Industry: N/A

Domainkarunahealth.net

Year Founded2018

Employees201 - 500

Annual Revenue$50M - $75M

Karuna Health, Inc.

Karuna Health, Inc. (including company regionals)

karunahealth.net

See more website traffic and engagement information

Karuna Health, Inc. Revenue up to March 2026 is 50M - 75M

revenue generated by Karuna Health, Inc. top domains

Karuna Health, Inc. top domains revenue over 3 years

Revenue for Karuna Health, Inc. top domains

karunahealth.net50M - 75M

See more with Sales Intelligence

Total visits to Karuna Health, Inc.'s top domains

Understand Karuna Health, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

karunahealth.net1.4K

See more with Sales Intelligence

Avg. visit duration in Karuna Health, Inc.'s top domains

Analyze Karuna Health, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

karunahealth.net--

See more with Sales Intelligence

Avg. pageviews on Karuna Health, Inc.'s top domains

See how Karuna Health, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

karunahealth.net1.08

See more with Sales Intelligence

Karuna Health, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Karuna Health, Inc.

These are the website technologies, by industry, used by Karuna Health, Inc. top domains

Payment & Currencies (5)

Cart Functionality

Content Management System (3)

WordPress

eCommerce (3)

WooCommerce

Mobile (2)

Meta Viewport

More Technologies

4

See all

News & Signals from Karuna Health, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsKaruna Corporation hires Steve Paul as CEO.Steve Paul has been appointed CEO of US biotech Karuna, to lead development of the psychiatric drug xanomeline, a previously shelved project that he helped to develop at Eli Lilly in the 1990s.